Skip to main content

Table 1 Characteristics of recruited patients

From: Evaluation of SUVlean consistency in FDG and PSMA PET/MR with Dixon-, James-, and Janma-based lean body mass correction

  FDG PSMA DXA
N 48F, 42M 28M 20F, 20M
Age 58 ± 13 (17~91) 70 ± 7 (56~89) 60 ± 12
Weight (kg) 63 ± 14.4 (37~103) 70.7 ± 8.4 (54~87) 64.7 ± 12.6 (43~94)
BMI 23.11 ± 4.54 (14.5~32.5) 24.47 ± 2.55 (18.7~28.3) 23.47 ± 3.5 (15~31)
Height (cm) 165 ± 7 (150~183) 170 ± 5 (162~180) 165 ± 7 (152~180)
Time (min) 72 ± 14 141 ± 18 /
Dose (mCi/kg) 9.6 ± 1.7% 12.1 ± 3.1% /
Dose (MBq) 221 ± 50 314 ± 73 /
  1. BMI body mass index, FDG fluorodeoxyglucose, PSMA prostate-specific membrane antigen